BeyondSpring (NASDAQ:BYSI) Stock Price Down 1.4% – Here’s What Happened

BeyondSpring Inc. (NASDAQ:BYSI)’s share price was down 1.4% on Friday . The stock traded as low as $1.71 and last traded at $1.71. Approximately 4,718 shares changed hands during trading, a decline of 69% from the average daily volume of 15,068 shares. The stock had previously closed at $1.74.

BeyondSpring Trading Down 1.4 %

The company’s 50 day simple moving average is $1.69 and its 200-day simple moving average is $1.96.

Institutional Trading of BeyondSpring

An institutional investor recently bought a new position in BeyondSpring stock. Renaissance Technologies LLC acquired a new position in BeyondSpring Inc. (NASDAQ:BYSI) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 12,500 shares of the company’s stock, valued at approximately $30,000. Institutional investors and hedge funds own 40.29% of the company’s stock.

About BeyondSpring

BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.